Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
65,014
Total Claims
$2.7M
Drug Cost
1,497
Beneficiaries
$1,836
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-98%
Opioid rate vs peers
0.0% vs 2.2% avg
+30%
Cost per patient vs peers
$1,836 vs $1,411 avg
-7%
Brand preference vs peers
9.8% vs 10.6% avg
Brand vs Generic
Brand: 6,365 claims · $1.8M
Generic: 58,305 claims · $913K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 1,569 | $494K |
| Rivaroxaban | 313 | $127K |
| Sitagliptin Phosphate | 335 | $103K |
| Empagliflozin | 189 | $73K |
| Memantine Hcl | 2,246 | $71K |
| Dulaglutide | 80 | $63K |
| Insulin Glargine,hum.Rec.Anlog | 220 | $57K |
| Sacubitril/Valsartan | 142 | $56K |
| Mirabegron | 184 | $48K |
| Linagliptin | 124 | $42K |
| Atorvastatin Calcium | 3,686 | $39K |
| Fluticasone/Umeclidin/Vilanter | 60 | $38K |
| Fluticasone/Vilanterol | 76 | $32K |
| Memantine Hcl/Donepezil Hcl | 67 | $28K |
| Donepezil Hcl | 2,308 | $27K |
Prescribing Profile
Patient Profile
82
Avg Age
69%
Female
2.26
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data